Selexis CHO Cells in Suspension-1

Fact Sheets

Selexis enables biopharmaceutical companies to produce virtually any recombinant therapeutic protein, because we have the ability to understand and modify our cells to address productivity and expression challenges.

Research Cell Bank Development Factsheet thumbnail

Research Cell Bank Development

NOVEMBER 10, 2021

For over 20 years, Selexis has helped its partners to generate life-saving biologic medicines and vaccines rapidly and cost-effectively. The SUREtechnology Platform™ is being used by global partners, resulting in more than 140 biologic drug candidates in preclinical and clinical development and eight products in commercial manufacturing. Selexis can generate stable and high-expressing (up to 10 g/L in bioreactor*) research cell banks (RCBs) in as little as 8–12 weeks.

VIEW PDF

JSR LIFE SCIENCES innovation to de-risk and accelerate the discovery and development of new therapeutics

JSR Life Sciences using innovation to de-risk and accelerate the discovery and development of new therapeutics

NOVEMBER 10, 2021

JSR Life Sciences provides specialized technology, products, materials, and services to biopharmaceutical companies and life science researchers through the service offerings of its affiliates: Selexis, MBL, Crown and KBI Biopharma. JSR has created a framework that provides a fully integrated drug development process, from discovery through commercial production, that can accelerate development timelines and increase clinical success rates.

VIEW PDF

Selexis Corporate overview thumbnail

Selexis Corporate Overview

AUGUST 6, 2021

Selexis SA, a JSR Life Sciences company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines.

VIEW PDF

Selexis Customer Survey 2019

Selexis Customer Survey 2019

NOVEMBER 6, 2019

In 2019, Selexis  surveyed our partners to collect feedback and gain insight about our company and technology. With our partners’ insights, we can build upon our business, continue to advance our technology and enhance our overall partner experience.

View PDF

TRUST-INDEX® EMPLOYEE SURVEY

TRUST-INDEX® EMPLOYEE SURVEY

JUNE 14, 2018

Trust develops when credibility, respect and fairness thrive in a workplace. A culture of trust gives rise to camaraderie and pride. The survey uses 58 closed questions in the Trust-Index employee survey to find out how employees see the following dimensions in their company….

View PDF

Selexis Customer Survey Q2 2017

Selexis Customer Survey Q2 2017

AUGUST 4, 2017

In 2017, Selexis  surveyed our partners to collect feedback and gain insight about our company and technology. With our partners’ insights, we can build upon our business, continue to advance our technology and enhance our overall partner experience.

View PDF

Keywords: cell line development customer survey Selexis
JSR Life Sciences, KBI Biopharma, Selexis Overview

JSR Life Sciences, KBI Biopharma, Selexis Overview

JUNE 21, 2017

The Contract Development Manufacturing Organization of the 21st CenturyCombined Forces to Serve as the Biopharmaceutical Customer- and Patient-Focused CDMO with the Most Robust and Fastest “Gene to GMP” Service Offering in the Industry

View PDF

Keywords: KBI Biopharma JSR Life Sciences Gene to GMP Selexis Contract Development Manufacturing Organization CDMO CMO cell line